NBM-BMX, an HDAC8 Inhibitor, Overcomes Temozolomide Resistance in Glioblastoma Multiforme by Downregulating the β-Catenin/c-Myc/SOX2 Pathway and Upregulating p53-Mediated MGMT Inhibition

Although histone deacetylase 8 (HDAC8) plays a role in glioblastoma multiforme (GBM), whether its inhibition facilitates the treatment of temozolomide (TMZ)-resistant GBM (GBM-R) remains unclear. By assessing the gene expression profiles from short hairpin RNA of HDAC8 in the new version of Connecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Cheng-Yu, Ko, Huey-Jiun, Chiou, Shean-Jaw, Lai, Yu-Ling, Hou, Chia-Chung, Javaria, Tehseen, Huang, Zi-Yi, Cheng, Tai-Shan, Hsu, Tsung-I, Chuang, Jian-Ying, Kwan, Aij-Lie, Chuang, Tsung-Hsien, Huang, Chi-Ying F., Loh, Joon-Khim, Hong, Yi-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199487/
https://www.ncbi.nlm.nih.gov/pubmed/34072831
http://dx.doi.org/10.3390/ijms22115907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199487/
https://www.ncbi.nlm.nih.gov/pubmed/34072831
http://dx.doi.org/10.3390/ijms22115907

Ejemplares similares